Estazolam Structural Formula (Image 1)
Estazolam Tablet
Product Images NDC 0591-0744
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Estazolam (NDC 0591-0744). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Image 2)
Estazolam is a medication that comes in tablet form and is dispensed with a medication guide by pharmacists. The tablets contain 1mg of Estazolam, which should be stored in a tightly sealed container that's light-resistant. The dosage of Estazolam should be referred to in the accompanying product literature. The manufacturer is Watson Pharma Private Limited, located in Verna, Salcette Goa, and distributed by Actavis Pharma, Inc, located in Parsippany, New Jersey. The Lot/Exp coding area is below the NDC number 0591-0744-01.*
1 (Image 3)
This is a medication packaging for Estazolam Tablets, USP with NDC 0591-0745-01. Each tablet contains 2mg of Estazolam, USP. The medication guide should be dispensed to each patient by the pharmacist. The tablets come in a light-resistant container and must be stored at 20° to 25°C (68° to 77°F). The manufacturer is Watson Pharma Private Limited in India, and distributed by Actavis Pharma, Inc. The packaging contains a lot/exp coding area.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
